Navigation Links
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Date:11/6/2008

nic angina, the debilitating cardiac chest pain that affects more than nine million Americans each year," said Louis G. Lange, CV Therapeutics chairman and chief executive officer.

"Ranexa is a very well tolerated drug that can now be considered among the first drugs to be given to patients with chronic angina. Our commercial organization will actively focus on educating new and existing prescribers about these significant new labeling improvements," Lange added.

The most frequently reported adverse reactions during treatment with Ranexa in clinical trials were dizziness, headache, constipation and nausea. Complete updated prescribing information will be available at http://www.ranexa.com.

"Ranolazine may now take optimal medical therapy to an entirely new level, and may afford enhanced symptom relief," said Dr. William Boden, clinical chief, division of cardiovascular medicine, University at Buffalo Schools of Medicine & Public Health and principal investigator of the COURAGE study. "I have seen excellent safety, tolerability and symptom relief in the great majority of chronic angina patients for whom I have prescribed ranolazine," he added.

"As we have seen in the MERLIN-TIMI 36 trial and in clinical practice, patients with ischemia and angina can be at increased risk for arrhythmias and also often have diabetes. Considering its mechanism of action, established cardiovascular safety and observed reductions in arrhythmias and HbA1c, ranolazine now becomes an even more important drug in our treatment of chronic angina," said Dr. Eugene Braunwald, Distinguished Hersey Professor of Medicine at Harvard Medical School and chairman of the TIMI Study Group.

These significant new labeling changes were supported by a supplemental new drug application submitted in September 2007 that included data from the 6,560 patient MERLIN-TIMI 36 trial, which showed no adverse trend in death or arrhythm
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
2. FDA Approves Durameds LoSEASONIQUE(R) Oral Contraceptive
3. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
4. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
5. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
6. FDA Approves Fougeras Clotrimazole Cream USP 1%
7. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
8. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
9. Signalife Board Approves Merger
10. FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
11. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced ... complete 2015 first quarter financial statements and MD&A have been filed ... March 31,(in CDN$,000 except per share data) , 2015 ... 1,974 Gross profit , 1,531 , 329 Ebitda* ... 528 , (531) Basic earnings (loss) per share ...
(Date:6/1/2015)... 29, 2015 Research and Markets ( ... "Global Bioinformatics Market 2015-2019" report to ... global bioinformatics market to grow at a CAGR ... is a field of science that includes computational ... stored in DNA form and protein sequences in ...
(Date:6/1/2015)... Frederick MD (PRWEB) June 01, 2015 ... that they have entered into a commercial collaboration ... both companies will combine their technologies and work ... cell (MSC) regenerative technology. RoosterBio and Sistemic will ... and technologies to build more precise and relevant ...
(Date:6/1/2015)... , May 29, 2015 ... announced the addition of the "2015 ... report to their offering. ... the European immunoprotein diagnostic market, including emerging ... and strategic profiles of leading suppliers. ...
Breaking Biology Technology:Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3Global Bioinformatics Market 2015-2019 - Rapid Developments in Molecular Diagnostics 2Global Bioinformatics Market 2015-2019 - Rapid Developments in Molecular Diagnostics 3Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 2Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 3Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 4
... , , , , , ... , Welcome to the last of a series ... contains considerations for freezing and viability , staining of cells. , ... , For some cell cultures, especially ...
... , , , , Scott ... , , , , , ... powerful and sensitive technique , used by scientists to amplify ... thermal cycling conditions can be adjusted to use almost any DNA , ...
... , , , , Main Menu , ... TO SCROLL THROUGH , MENUS AND PROGRAMS. PRESS ENTER TO SELECT HIGHLIGHTED CHOICE) Menu ... , . , This confirms choice or input data ... , , , (press enter) , ...
Cached Biology Technology:The QIAGEN Guide to Animal Cell Culture 2The QIAGEN Guide to Animal Cell Culture 3Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 2Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 3Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 4Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 5Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 6Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 7Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 8Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 9Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 10Using the TripleMaster PCR System for Robust Amplification of , GC-Rich DNA Templates 11Mastercycler Gradient Quick Programming Guide 2
(Date:5/19/2015)... NEW YORK , May 19, 2015  Technology ... resources both internally and in the cloud. Passwords and ... the use of OTP and standards-based specifications such as ... that the outmoded use of passwords presents for BYOD, ... needs a unified biometric identity protocol. ...
(Date:5/18/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
(Date:5/14/2015)... YORK , May 14, 2015 /PRNewswire/ ... in identity verification and online remote proctoring, ... a software-as-a-service (SaaS) company and creator of ... customers of the two companies will benefit ... in Canvas. As a fully ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... but when it cracks or otherwise fails, it proves ... tend to be toughthey resist shatteringbut are also relatively ... ideal material, says Marios Demetriou, a senior research fellow ... advantage of being both strong and tougha combination called ...
... In the late 1950s, Richard Feynman famously imagined a ... by manipulating matter and creating structures all the way ... over fifty years after "There,s Plenty of Room at ... Angela Belcher, Donald Eigler, and Michael Roukes - are ...
... When most people in the developed world think ... dim memory of a vaccination at a pediatrician,s office. ... North America and much of Europe, researchers remain interested ... because improving the measles vaccine could help eliminate the ...
Cached Biology News:Caltech-led team creates damage-tolerant metallic glass 2Caltech-led team creates damage-tolerant metallic glass 3Caltech-led team creates damage-tolerant metallic glass 4Scaling up: The future of nanoscience 2Scaling up: The future of nanoscience 3Measles virus, a weapon against cancer? 2